Showing results (71-80 of 93) with videos related to
Sort By:
Pageof 10
Gynecologic Oncology|April 14, 2016
Optimal cytoreductive surgery in patients with advanced uterine carcinosarcoma: A multi-institutional retrospective study from the Japanese gynecologic oncology groupKenichi Harano, Akihiro Hirakawa, Mayu Yunokawa, et al.Cancer Science|July 15, 2010
Tobacco smoking and regression of low-grade cervical abnormalitiesKoji Matsumoto, Akinori Oki, Reiko Furuta, et al.The Journal of Obstetrics and Gynaecology Research|April 24, 2026
Clinicopathological Status and Prognostic Factors of Recurrent Epithelial Ovarian Cancer in Japan: Retrospective Survey of JSOG Committee on Gynecologic OncologyYoh Watanabe, Tsukasa Baba, Shu Soeda, et al.International Journal of Clinical Oncology|July 13, 2011
Subsequent risks for cervical precancer and cancer in women with low-grade squamous intraepithelial lesions unconfirmed by colposcopy-directed biopsy: results from a multicenter, prospective, cohort studyKoji Matsumoto, Yasuo Hirai, Reiko Furuta, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2012
HLA class II DRB1*1302 allele protects against progression to cervical intraepithelial neoplasia grade 3: a multicenter prospective cohort studyKoji Matsumoto, Hiroo Maeda, Akinori Oki, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 28, 2014
Paclitaxel and carboplatin in patients with completely or optimally resected carcinosarcoma of the uterus: a phase II trial by the Japanese Uterine Sarcoma Group and the Tohoku Gynecologic Cancer UnitAi Otsuki, Yoh Watanabe, Hiroyuki Nomura, et al.International Journal of Clinical Oncology|October 26, 2012
Association between carotenoids and outcome of cervical intraepithelial neoplasia: a prospective cohort studyTakuma Fujii, Naoyoshi Takatsuka, Chisato Nagata, et al.JAMA Oncology|March 22, 2019
Effect of Taxane Plus Platinum Regimens vs Doxorubicin Plus Cisplatin as Adjuvant Chemotherapy for Endometrial Cancer at a High Risk of Progression: A Randomized Clinical TrialHiroyuki Nomura, Daisuke Aoki, Hirofumi Michimae, et al.Anticancer Research|April 1, 2009
Favourable prognosis with modified dosing of docetaxel and cisplatin in Japanese patients with ovarian cancerDaisuke Aoki, Yoh Watanabe, Toshiko Jobo, et al.Cancer Science|August 4, 2015
Human leukocyte antigen class II DRB1*1302 allele protects against cervical cancer: At which step of multistage carcinogenesis?Koji Matsumoto, Hiroo Maeda, Akinori Oki, et al.Pageof 10